Results
11
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
11 companies
Zhejiang CONBA PharmaceuticalLtd
Market Cap: CN¥10.7b
Engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China.
600572
CN¥4.35
7D
-2.0%
1Y
-4.8%
Tianjin Chase Sun PharmaceuticalLtd
Market Cap: CN¥11.0b
Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.
300026
CN¥3.66
7D
-2.4%
1Y
1.7%
Guizhou Xinbang Pharmaceutical
Market Cap: CN¥6.5b
Researches, develops, manufactures, and sells Chinese herbal medicines and other pharmaceutical products in China and internationally.
002390
CN¥3.42
7D
-3.1%
1Y
0.6%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥7.0b
Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China.
002437
CN¥3.11
7D
-7.4%
1Y
51.0%
Fuan Pharmaceutical (Group)
Market Cap: CN¥5.1b
Research and develops, produces, and sells chemical drugs in the People's Republic of China.
300194
CN¥4.29
7D
-2.9%
1Y
2.6%
Hunan Er-Kang Pharmaceutical
Market Cap: CN¥7.2b
Manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally.
300267
CN¥3.49
7D
-4.4%
1Y
38.5%
Tiansheng Pharmaceutical Group
Market Cap: CN¥1.6b
Engages in the pharmaceutical manufacturing and circulation activities.
002872
CN¥4.89
7D
-6.1%
1Y
27.3%
Chongqing Lummy Pharmaceutical
Market Cap: CN¥4.6b
Engages in the research and development, manufacture, and sale of pharmaceutical products in China.
300006
CN¥4.31
7D
-2.5%
1Y
38.6%
Guizhou Yibai Pharmaceutical
Market Cap: CN¥3.2b
Researches, develops, produces, and sells pharmaceutical products in China.
600594
CN¥4.06
7D
-3.8%
1Y
13.7%
Qinghai Spring Medicinal Resources Technology
Market Cap: CN¥2.8b
Qinghai Spring Medicinal Resources Technology Co., Ltd.
600381
CN¥4.91
7D
-2.0%
1Y
63.7%
Dezhan Healthcare
Market Cap: CN¥8.8b
Engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People’s Republic of China.
000813
CN¥4.31
7D
-1.1%
1Y
55.0%